Ligand Pharmaceuticals Inc. (NASDAQ: LGND) Attends 31st Annual ROTH Conference
Ligand Pharmaceuticals (NASDAQ: LGND) is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Ligand’s business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Ligand’s business model is based on drug discovery, early-stage drug development, product reformulation and partnering. Ligand has established multiple alliances, licenses and other business relationships with the world's leading pharmaceutical companies including Novartis, Amgen, Merck, Pfizer, Celgene, Gilead, Janssen, Baxter International and Eli Lilly. For more information, visit…







